Literature DB >> 8380909

Use of polymerase chain reaction to demonstrate cytomegalovirus DNA in CSF of patients with human immunodeficiency virus infection.

D B Clifford1, R S Buller, S Mohammed, L Robison, G A Storch.   

Abstract

We used the polymerase chain reaction (PCR) to demonstrate cytomegalovirus (CMV) DNA in the CSF of a patient with the CMV radiculomyelopathy syndrome. To investigate the significance of this finding, we also performed PCR for CMV on CSF samples from 30 patients with human immunodeficiency virus (HIV) infection and neurologic disease, four patients with solid organ transplants including three with active CMV infection, and 10 patients with no clinical suspicion of HIV or CMV infection. There was CMV DNA only in patients with HIV, and it was present more often in patients with evidence of spinal cord dysfunction. Our results suggest that PCR may be useful in the rapid diagnosis of CMV infection of the CNS in patients with HIV and that the radiculomyelopathy syndrome may represent only part of a spectrum of CMV-induced spinal cord dysfunction in these patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8380909     DOI: 10.1212/wnl.43.1_part_1.75

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  14 in total

1.  Comparison of three nucleic acid amplification assays of cerebrospinal fluid for diagnosis of cytomegalovirus encephalitis.

Authors:  A Bestetti; C Pierotti; M Terreni; A Zappa; L Vago; A Lazzarin; P Cinque
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

Review 2.  Recurrent polymorphonuclear pleocytosis with increased red blood cells caused by varicella zoster virus infection of the central nervous system: Case report and review of the literature.

Authors:  Aaron Haug; Ravi Mahalingam; Randall J Cohrs; D Scott Schmid; John R Corboy; Don Gilden
Journal:  J Neurol Sci       Date:  2010-02-19       Impact factor: 3.181

3.  Acute lumbosacral polyradiculopathy due to cytomegalovirus in advanced HIV disease: CSF findings in 17 patients.

Authors:  R F Miller; J D Fox; P Thomas; J C Waite; Y Sharvell; B G Gazzard; M J Harrison; N S Brink
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-11       Impact factor: 10.154

Review 4.  Central nervous system infection during immunosuppression.

Authors:  Joseph R Zunt
Journal:  Neurol Clin       Date:  2002-02       Impact factor: 3.806

5.  Criteria for reducing unnecessary testing for herpes simplex virus, varicella-zoster virus, cytomegalovirus, and enterovirus in cerebrospinal fluid samples from adults.

Authors:  Craig B Wilen; Cynthia L Monaco; Joan Hoppe-Bauer; Ronald Jackups; Robert C Bucelli; Carey-Ann D Burnham
Journal:  J Clin Microbiol       Date:  2015-01-07       Impact factor: 5.948

6.  Detection of human cytomegalovirus pp67 late gene transcripts in cerebrospinal fluid of human immunodeficiency virus type 1-infected patients by nucleic acid sequence-based amplification.

Authors:  F Zhang; S Tetali; X P Wang; M H Kaplan; F V Cromme; C C Ginocchio
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

Review 7.  CNS manifestations of cytomegalovirus infections: diagnosis and treatment.

Authors:  Matthias Maschke; Oliver Kastrup; Hans-Christoph Diener
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 8.  HIV-associated peripheral neuropathy: epidemiology, pathophysiology and treatment.

Authors:  E A Wulff; A K Wang; D M Simpson
Journal:  Drugs       Date:  2000-06       Impact factor: 9.546

9.  Relevance of clinical and laboratory findings in the diagnosis of cytomegalovirus encephalitis in patients with AIDS.

Authors:  C Mussini; N Mongiardo; G Manicardi; F Trenti; A Alessandrì; F Paolillo; A Catania; M Portolani; M Pecorari; V Borghi; G Ficarra; A Cossarizza; B De Rienzo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-06       Impact factor: 3.267

10.  Human cytomegalovirus DNA in cerebrospinal fluid.

Authors:  J Kohyama; M Kajiwara; M Shimohira; Y Iwakawa; H Okawa
Journal:  Arch Dis Child       Date:  1994-11       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.